ask="1.8000"
ask_size="200"
average_daily_volume="51635"
bid="1.2000"
bid_size="1200"
book_value="0.9470"
change="-0.0137"
change_from_200_day_moving_average="-0.1507"
change_from_50_day_moving_average="-0.0434"
change_from_52_week_high="-0.9636"
change_From_52_week_low="0.1163"
change_in_percent="-1.0787%"
close="1.2563"
dividend_pay_date="11/8/2012"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-0.7500"
ebitda="-28.78M"
eps_estimate_current_year="-0.9200"
eps_estimate_next_quarter="-0.2000"
eps_estimate_next_year="-1.0700"
ex_dividend_date="11/9/2012"
float_shares="30545000"
high="1.2999"
high_52_weeks="2.2199"
last_trade_date="1/12/2017"
last_trade_price="1.2563"
last_trade_size="166"
last_trade_time="3:58pm"
low="1.2400"
low_52_weeks="1.1400"
market_capitalization="48.54M"
moving_average_200_day="1.4070"
moving_average_50_day="1.2997"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.1700"
open="1.2899"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-10.7095%"
percent_change_from_50_day_moving_average="-3.3392%"
percent_change_from_52_week_high="-43.4074%"
percent_change_from_52_week_low="+10.2018%"
previous_close="1.2700"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.3411"
price_per_sales="6.3731"
revenue="7.70M"
shares_outstanding="38640000"
short_ratio="4.2600"
stock_exchange="NMS"
symbol="AVIR"
volume="41300"
weeks_range_52="1.1400 - 2.2199"
